CHEMSAVE is highlighting its limited-time special offer, which offers great value on its membership fees.
See more on the back page.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
PFIZER Australia’s Vyndamax (tafamidis) is now listed on the PBS for treating fatal heart conditions related to amyloid disorders.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
